Alkermes (ALKS) Stock Price, Quote, News & History | Benzinga

SPY774.26+0.60%QQQ754.52+0.66%BTC/USD85,315.00−1.39%DIA511.83+0.14%GLD378.51−0.43%TLT76.71−0.99%

Alkermes PLC (ALKS) Stock Price, Quote, News & History

ALKSNASDAQ

Trade with Public

Trade with Public

$42.70

0.952.28%

Last update: Oct 5, 1:28 PM

$41.50

-0.25-0.6%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$42.07

Close

-

Volume / Avg.

968.81K / 1.81M

Day Range

$41.67 - $42.92

52 Wk Range

27.00 - 55.67

Market Cap

$7.16B

P/E Ratio

109.91

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

12.52%

Days to Cover

10.7

Recent Alkermes Plc News

Meta To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday

Analysts upgraded Fifth Third to Buy and adjusted price targets for Exelon, Alaska Air, Fair Isaac, Meta, Alkermes, Twilio and Warner Bros. Discovery.

Avi Kapoor

Alkermes Says Experimental Drug Could Open New Path in ADHD Treatment

Alkermes reports positive Phase 1b data for ALKS 7290, showing clinical proof-of-concept for ADHD treatment. Learn key findings.

Vandana Singh

Alkermes Says Lead Drug Maintains Wakefulness Benefits in Long-Term Narcolepsy Study

Alkermes reports positive long-term data for alixorexton, showing sustained wakefulness and symptom improvements in NT1 and NT2 narcolepsy.

Vandana Singh

This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrades, and initiations on analyst ratings page.

Avi Kapoor

Micron To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday

Top analysts changed outlook on top names: Intuit downgraded, Alkermes price target raised, Carmax target increased, Sezzle target up, Biogen target raised, Progressive target cut.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

251.18M

Investing Cash Flow (TTM)

-1.76B

Financing Cash Flow (TTM)

1.50B

Free Cash Flow (TTM)

221.65M

Capital Expenditure (TTM)

-29.53M

Net Change in Cash (TTM)

-9.67M

Analyst Trends and Forecast

1

Apr

4

May

5

1

Jun

5

2

Jul

3

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$7.92B

PE Ratio (TTM)

109.91

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.20

PB Ratio (TTM)

3.87

Earnings Yield % (TTM)

0.91%

Earnings Yield % (FWD)

0.00%

EV / EBITDA (TTM)

36.33

Price / EBITDA (TTM)

32.14

Price / Free Cash Flow (TTM)

31.62

Book Value / Share

$10.78

Company Debt

Total Debt

$1.50B

LT Debt

$1.48B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$6.63M

Total Cash

$511.53M

Debt to Equity

0.87

Issuance of Debt (TTM)

$1.50B

Repayment of Debt (TTM)

-$6.63M